Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge metastatic breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

ASCO Recommends Palliative Care with Standard Cancer Treatment

February 29, 2012

Learn how new research has prompted the American Society of Clinical Onclolgy (ASCO) to recommend that doctors offer palliative care alongside standard medical treatment for people diagnosed with metastatic cancers.

Astra takes brand cancer drug straight to patients

February 17, 2012

(Reuters) - AstraZeneca Plc is selling breast cancer drug Arimidex directly to U.S. patients, offering an option for people who want to pay for the brand instead of generic versions.

FDA staff unsure about new use for Amgen's Xgeva

February 6, 2012

WASHINGTON (Reuters) - Reviewers from the U.S. Food and Drug Administration said on Monday that they were not sure whether Amgen Inc's Xgeva bone drug should be approved for a wider use of delaying the spread of cancer to the bone.

Medicine Combination Slows Metastatic Hormone Positive Breast Cancer

February 1, 2012

Learn how the combination of everolimus and the hormonal therapy exemestane may offer a new treatment option for postmenopausal women with locally advanced or metastatic estrogen-receptor positive, HER2-negative breast cancer.

Medicine Combination Slows Metastatic HER2 Positive Breast Cancer

January 26, 2012

Learn how the experiemental medicine pertuzumab improves progression-free survival and may offer a new treatment option for women with metastatic HER2 positive breast cancer.

U.S. revokes approval of Avastin for breast cancer

November 18, 2011

WASHINGTON (Reuters) - U.S. drug regulators on Friday withdrew approval of Roche's Avastin as a treatment for breast cancer, capping a protracted and emotional battle over a drug backed by many survivors of the disease.

Doctors split on Avastin for breast cancer: survey

October 26, 2011

NEW YORK (Reuters Health) - An international survey of cancer doctors shows many question U.S. health advisers' 2010 rejection of Roche's drug Avastin to treat advanced breast cancer.

Calif. insurer won't pay for breast cancer drug

October 3, 2011

(Reuters) - Health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial.

Novartis's Afinitor shows promise in breast cancer

September 26, 2011

STOCKHOLM (Reuters) - Combining two drugs from Novartis and Pfizer to treat post-menopausal women with a certain type of advanced breast cancer more than doubled the time they lived without their disease getting worse, study data showed on Monday.

Roche's pertuzumab helps breast cancer patients

July 15, 2011

ZURICH (Reuters) - Patients with advanced breast cancer lived significantly longer without their disease getting worse when treated with Roche's pertuzumab and Herceptin along with a type of chemotherapy, a late-stage study showed.

Denver, CO  ·  September 13, 2014

Join Your Community for Yoga on the Steps!

Close
close